Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogeneA (UBA52 pseudogeneA; ENSG00000239622) is a human pseudogene related to the functional UBA52 gene. Pseudogenes resemble known genes but are generally non-functional due to mutations or lack of regulatory elements; they do not encode proteins. Although pseudogenes were once considered "junk DNA," some are transcribed, and their RNA products can participate in regulatory networks by acting as decoys for microRNAs or generating non-coding RNAs that influence gene expression. However, this specific pseudogene is not considered a drug target or biomarker and does not encode an active protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogeneA (UBA52 pseudogeneA).